Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Spectrum Pharmaceuticals, Inc
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed biliary tract or gallbladder cancer that have relapsed or are refractory after one prior gemcitabine-based chemotherapy regimen for advanced biliary cancer
Evaluable disease
ECOG PS ≤ 2
Adequate bone marrow, liver and renal function
You may not be if
Treatment with more than one prior chemotherapy regimen
Known, uncontrolled CNS metastases
Baseline peripheral neuropathy ≥ grade 2.
Significant circulatory disorders in the past 6 months
